News Themis Medicare Limited NSE India S.E.

Equities

THEMISMED

INE083B01024

Market Closed - NSE India S.E. Other stock markets 12:43:53 10/06/2024 BST			5-day change	1st Jan Change
216.3 ^INR	+3.50%		+6.69%	+1.22%

05-14	Themis Medicare Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
05-14	Themis Medicare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Themis Medicare Limited Recommends Dividend for Financial Year Ended March 31, 2024, Payable on or after July 22, 2024	05-14	CI
Themis Medicare Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-14	CI
Themis Medicare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-14	CI
Themis Medicare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-10	CI
Themis Medicare Limited Launches REMITHEM	11-10	CI
Themis Medicare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-04	CI
Split: 10 of 1	09/10/23	FA
Split: 10 of 1	09/10/23	FA
Themis Medicare Limited Announces Incorporation of Wholly Owned Subsidiary	20/09/23	CI
Themis Medicare Limited Announces Cessation of Vijay Agarwal as Independent Director	09/09/23	CI
Themis Medicare Limited Appoints Reena Patel as Alternate Non-Executive Non- Non-Independent Director to Dr. Adam Demeter, Effective September 11, 2023	07/09/23	CI
Ex-dividend day for final dividend	31/08/23	FA
Themis Medicare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10/08/23	CI
Themis Medicare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	13/05/23	CI
Themis Medicare Limited Reports Earnings Results for the Full Year Ended March 31, 2023	13/05/23	CI
Themis Medicare Limited Recommends Dividend for Financial Year Ended 31 March 2023	13/05/23	CI
Themis Medicare Limited Announces Board Resignations	02/05/23	CI
Themis Medicare Gets Drug Controller General of India’s No-Objection for Diclofenac Injection	17/02/23	MT
Themis Medicare Announces DCGI Approval of Remifentanil Hydrochloride 1mg/2mg for Injection for Import and Marketing	17/02/23	CI
Themis Medicare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	03/02/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Themis Medicare Limited NSE India S.E.

Equities

THEMISMED

INE083B01024

Summary

Filters